J&J Says It Won’t Make an Offer for Horizon Therapeutics

Johnson & Johnson said it doesn’t intend to make an offer for Horizon Therapeutics Plc, days after the developer of medicines for rare autoimmune and inflammatory diseases revealed it was in talks with the company.

Bloomberg